Publication | Closed Access

Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial

Metabolic SyndromeCommon Antidiabetes TreatmentsDiabetes ManagementCardiovascular DiseaseDiabetesClinical TrialsType 2Placebo-controlled TrialPharmacotherapyDiabetes MellitusMedicineHealth Sciences